In 2017, Dr. Hair Bejo received the WVPA-Merial Innovation in Vaccination Award for his outstanding contributions.
Dr. Hair Bejo's work reached a pinnacle in 2005 when he successfully developed and commercialised the MyVAC UPM93 IBD vaccine. His team's research and field trials demonstrated its safety and effectiveness in controlling the disease.
Continuing his dedication, Dr. Hair Bejo focuses on researching and developing new-generation vaccines to enhance poultry health. He explores the use of green technology and nanotechnology for safer and healthier poultry production, with breakthroughs in cationic liposomes and anolytes. Actively involved in commercialising research products, he also works on bacterial vaccines to reduce antibiotic use, mitigating the risk of antimicrobial resistance.
With an extensive publication record and participation in international conferences, Dr. Hair Bejo contributes significantly to scientific literature. His dedication to excellence is reflected in his Scopus, intellectual property achievements, and international recognition.